GENERAL ATLANTIC, L.P.
Follow13F filer, CIK 1017645, New York, NY
GENERAL ATLANTIC, L.P. reported $2,809,301,527 across 16 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-07. Its ten largest share positions make up 97.02% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950142-25-000283
- Period
- 2024-12-31
- Reported value
- $2.81B
- Holdings
- 16
- Top 10 weight
- 97.02%
- New
- 0
- Sold out
- 2
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| ADAGadded | +3,561,952 | $7.09M |
| THRDadded | +413,561 | $4.26M |
| GROVadded | +1,538,839 | $2.14M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| SQUARESPACE INCexited | -10,611,073 | -$493M |
| ALKTreduced | -5,875,000 | -$215M |
| BLNDexited | -19,132,440 | -$71.7M |
| ACELYRIN INCreduced | -194,341 | -$610K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q4 2024
Share positions as resolved from 13F-HR 0000950142-25-000283, largest first. % of portfolio is the value over $2,809,301,527, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| DLODLOCAL LTD | 63,906,695 | $720M | 25.61% | 0 | Timeline | ||
| ALHCALIGNMENT HEALTHCARE INC | 60,993,323 | $686M | 24.43% | 0 | Timeline | ||
| ALKTALKAMI TECHNOLOGY INC | 9,645,318 | $354M | 12.59% | -5,875,000 | Timeline | ||
| XPXP INC | 29,617,733 | $351M | 12.49% | 0 | Timeline | ||
| CNTACENTESSA PHARMACEUTICALS PLC | 9,681,818 | $162M | 5.77% | 0 | Timeline | ||
| AKROAKERO THERAPEUTICS INC | 5,233,989 | $146M | 5.18% | 0 | Timeline | ||
| PHVSPHARVARIS N V | 7,531,252 | $144M | 5.14% | 0 | Timeline | ||
| EWCZEUROPEAN WAX CTR INC | 13,110,492 | $87.4M | 3.11% | 0 | Timeline | ||
| RPRXROYALTY PHARMA PLC | 1,500,000 | $38.3M | 1.36% | 0 | Timeline | ||
| IMCRIMMUNOCORE HLDGS PLC | 1,261,684 | $37.2M | 1.32% | 0 | Timeline | ||
| THRDTHIRD HARMONIC BIO INC | 3,372,323 | $34.7M | 1.24% | +413,561 | Timeline | ||
| RSKDRISKIFIED LTD | 5,324,998 | $25.2M | 0.9% | 0 | Timeline | ||
| ACELYRIN INCACELYRIN INC | 2,695,327 | $8.46M | 0.3% | -194,341 | |||
| ADAGADAGENE INC | 3,825,952 | $7.61M | 0.27% | +3,561,952 | Timeline | ||
| CONTEXTLOGIC INCCONTEXTLOGIC INC | 609,616 | $4.29M | 0.15% | 0 | |||
| GROVGROVE COLLABORATIVE HOLD INC | 2,474,859 | $3.44M | 0.12% | +1,538,839 | Timeline |
Sold out in Q4 2024
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| SQUARESPACE INCSQUARESPACE INC | 10,611,073 | $493M | shares |
| BLNDBLEND LABS INC | 19,132,440 | $71.7M | shares |
How Q4 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950142-25-000283 | base | 2025-02-07 | acceptance time not in the bulk data set |